Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Chemically, it is a 39-amino acid peptide analog with an attached fatty acid side chain that facilitates its binding to albumin and prolongs its presence in the bloodstream
This might involve dose adjustment, additional symptomatic treatment, or consideration of alternative diabetes medications if side effects prove intolerable despite appropriate management strategies
Tirzepatide is the active ingredient in Mounjaro and Zepbound Tirzepatide vs Semaglutide: Greater weight loss with tirzepatide as seen in clinical trials: 21.1% average weight reduction with tirzepatide 10-15% average weight reduction with semaglutide Less side effects reported with tirzepatide Less risk of hypoglycemia with tirzepatide How it works: Targets areas in the brain that suppresses appetite and reduces cravings Delays digestion and stomach emptying leaving you feeling fuller for a longer period of time, more satisfied with smaller meals and smaller portions leading to weight loss With it's combined positive benefits to blood pressure, cholesterol, and blood sugar, Tirzepatide positively impacts your cardiovascular health and decreases your risk for heart disease.
